SMC1A is abundantly expressed in prostatic carcinoma, and knockdown of SMC1A might inhibit cell proliferation, growth, migration, and cancer stem-like cell features, while also improving the effectiveness of radiation treatment [9, 10]. Here, SMC1A is linked to prostate carcinoma.